The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus

Blood
Richard M DunhamGuido Silvestri

Abstract

In contrast to human immunodeficiency virus (HIV)-infected humans, natural hosts for simian immunodeficiency virus (SIV) very rarely progress to acquired immunodeficiency syndrome (AIDS). While the mechanisms underlying this disease resistance are still poorly understood, a consistent feature of natural SIV infection is the absence of the generalized immune activation associated with HIV infection. To investigate the immunologic mechanisms underlying the absence of AIDS in SIV-infected sooty mangabeys (SMs), a natural host species, we performed a detailed analysis of the SIV-specific cellular immune responses in 110 SIV-infected SMs. We found that while SIV-specific T-cell responses are detectable in the majority of animals, their magnitude and breadth are, in fact, lower than what has been described in HIV-infected humans, both in terms of cytokine production (ie, IFN-gamma, TNF-alpha, and IL-2) and degranulation (ie, CD107a expression). Of importance, SIV-specific T-cell responses were similarly low when either SIVmac239-derived peptides or autologous SIVsmm peptides were used as stimuli. No correlation was found between SIV-specific T-cell responses and either viral load or CD4+ T-cell count, or between these responses and m...Continue Reading

References

Jun 1, 1989·Nature·V M HirschP R Johnson
Jun 7, 1985·Science·M D DanielR C Desrosiers
Jan 1, 1985·Journal of Molecular Evolution·M HasegawaT Yano
Jan 26, 1995·The New England Journal of Medicine·G PantaleoL K Schrager
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·D A PriceR E Phillips
Mar 23, 2001·Nature Immunology·M D HazenbergF Miedema
Oct 12, 2001·Immunology Letters·S A Migueles, M Connors
Apr 3, 2002·Nature Medicine·Zvi GrossmanWilliam E Paul
Jul 2, 2003·Nature Medicine·Mario Stevenson
Sep 17, 2003·The Journal of Clinical Investigation·Guido Silvestri, Mark B Feinberg
Dec 17, 2003·The Journal of Experimental Medicine·Souheil-Antoine YounesRafick-Pierre Sekaly
Feb 11, 2004·Nature Medicine·A J LeslieP J R Goulder
Feb 18, 2004·Nature Medicine·Thomas C FriedrichDavid I Watkins
Apr 7, 2004·The Journal of Clinical Investigation·David A GarberMark B Feinberg
Apr 30, 2004·The New England Journal of Medicine·Justin StebbingDaniel C Douek
Jul 29, 2004·Journal of Virology·Binhua LingPreston A Marx
Mar 12, 2005·The Journal of Clinical Investigation·Christopher KornfeldMichaela C Müller-Trutwin

❮ Previous
Next ❯

Citations

Apr 16, 2009·Current Infectious Disease Reports·Alexandra M Ortiz, Guido Silvestri
Nov 5, 2013·Veterinary Microbiology·R F CookC J Issel
Nov 18, 2006·Nature Immunology·Jonathan L Heeney, Stanley A Plotkin
Dec 8, 2006·Nature Medicine·Barton F Haynes
Aug 9, 2008·The New England Journal of Medicine·Bruce D Cheson, John P Leonard
Jan 14, 2012·Current Opinion in HIV and AIDS·Vasudha SundaravaradanDonald L Sodora
Feb 28, 2008·AIDS·Donald L Sodora, Guido Silvestri
Jul 2, 2010·Proceedings. Biological Sciences·Ming Liang ChanMiles P Davenport
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Nichole R KlattVanessa Hirsch
Mar 10, 2012·Science·Ann ChahroudiGuido Silvestri
Oct 17, 2006·Clinical Microbiology Reviews·Sue VandeWoude, Cristian Apetrei
Sep 29, 2006·Journal of Clinical Microbiology·Greg BrennanSue VandeWoude
Dec 26, 2008·Journal of Virology·José-Manuel Lozano ReinaMichaela C Müller-Trutwin
Jan 25, 2008·Journal of Virology·Ivona PandreaCristian Apetrei
Jul 28, 2009·Annual Review of Medicine·Mirko PaiardiniGuido Silvestri
Nov 3, 2007·The Journal of Clinical Investigation·Guido SilvestriDonald L Sodora
May 24, 2008·The Journal of Clinical Investigation·Nichole R KlattAftab A Ansari
Dec 5, 2009·The Journal of Clinical Investigation·Steven E BosingerDavid J Kelvin
Oct 19, 2011·The Journal of Clinical Investigation·Alexandra M OrtizGuido Silvestri
Aug 8, 2008·Future Oncology·Madeleine Duvic, Rakhshandra Talpur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.